Question special
Chief Resident

During the last 10 days, we enjoyed discussing different aspects of the PREVENT trial including background, methodology and results. We have had though provoking questions with great answers. Based on the results of this trial, there is good evidence that dual therapy is not more effective than therapy alone and we should reconsider adding on IPC for VTE prophylaxis, taking into consideration the population that was included in this trial. Thank you authors for this excellent work.
Sincerely thanks to all who participated residents, faculty and authors. We appreciate everyone that supported this amazing educational experience and we also thank the NEJM group for making this GLOBAL journal club possible. Any final thought is welcome.